Usefulness of calcaneal quantitative ultrasound stiffness for the evaluation of bone health in HIV-1-infected subjects: comparison with dual X-ray absorptiometry

References

• BattaloraLAYoungBOvertonETBones, fractures, antiretroviral therapy and HIVCurr Infect Dis Rep201416239324535243
   PubMed Web of Science ®Google Scholar
• EffrosRBFletcherCVGeboKAging and infectious diseases: workshop on HIV infection and aging: what is known and future research directionsClin Infect Dis200847454255318627268
   PubMed Web of Science ®Google Scholar
• OnenNFOvertonETSeyfriedWAging and HIV infection: a comparison between older HIV-infected persons and the general populationHIV Clin Trials201011210010920542846
   PubMed Web of Science ®Google Scholar
• BrownTTQaqishRBAntiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic reviewAIDS200620172165217417086056
   PubMed Web of Science ®Google Scholar
• TriantVABrownTTLeeHGrinspoonSKFracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare systemJ Clin Endocrinol Metab20089393499350418593764
   PubMed Web of Science ®Google Scholar
• OvertonETMondyKBushTJFactors associated with low bone mineral density (BMD) in a cohort of HIV-infected U.S. adults-baseline results from the SUN Study13th Conference on Retroviruses and Opportunistic InfectionsFebruaryLos Angeles, CA2007 Abstract 836
   Google Scholar
• McComseyGATebasPShaneEBone disease in HIV infection: a practical review and recommendations for HIV care providersClin Infect Dis201051893794620839968
   PubMed Web of Science ®Google Scholar
• HansenABGerstoftJKronborgGIncidence of low- and high-energy fractures in persons with and without HIV-infection: a Danish population based cohort studyAIDS201226328529322095195
   PubMed Web of Science ®Google Scholar
• AngeliAGuglielmiGDovioAHigh prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient studyBone200639225325916574519
   PubMed Web of Science ®Google Scholar
• ZenilmanJMHookEWShepherdMSmithPRompaloAMCelentanoDDAlcohol and other substance use in STD clinic patients: relationships with STDs and prevalent HIV infectionSex Transm Dis19942142202257974074
   PubMed Web of Science ®Google Scholar
• Kwan TatSPadrinesMThéoleyreSHeymannDFortunYIL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiologyCytokine Growth Factor Rev2004151496014746813
   PubMed Web of Science ®Google Scholar
• PepeJMezzaromaIFantauzziAAn oral high dose of cholecalciferol restores vitamin D status in deficient postmenopausal HIV-1-infected women independently of protease inhibitors therapy: a pilot studyEndocrine Epub201589
   Web of Science ®Google Scholar
• DongHVCortésYIShiauSYinMTOsteoporosis and fractures in HIV/hepatitis C virus coinfection: a systematic review and meta-analysisAIDS201428142119213124977441
   PubMed Web of Science ®Google Scholar
• McComseyGAKitchDDaarESBone mineral density and fractures in antiretroviral naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG A5202J Infect Dis2011203121791180121606537
   PubMed Web of Science ®Google Scholar
• HilemanCOLabbatoDEStorerNJTangprichaVMcComseyGAIs bone loss linked to chronic inflammation in antiretroviral-naive HIV-infected adults? A 48-week matched cohort studyAIDS201428121759176724871454
   PubMed Web of Science ®Google Scholar
• Walker HarrisVBrownTTBone loss in the HIV-infected patient: evidence, clinical implications, and treatment strategiesJ Infect Dis2012205Suppl 3S391S39822577213
   PubMed Web of Science ®Google Scholar
• European AIDS Clinical SocietyGuidelines: Prevention and Management of Non-infectious Comorbidities in HIV2014 Available from: http://www.europeanaidsclinicalsociety.org/images/stories/EACSPdf/EacsGuidelines-v8.0-1edition.pdfAccessed October 2015
   Google Scholar
• BrownTTHoyJBorderiMRecommendations for evaluation and management of bone disease in HIVClin Infect Dis20156081242125125609682
   PubMed Web of Science ®Google Scholar
• GourlayMLFineJPPreisserJSStudy of Osteoporotic Fractures Research Group. Bone-density testing interval and transition to osteoporosis in older womenN Engl J Med2012366322523322256806
   PubMed Web of Science ®Google Scholar
• NegredoEBonjochAGómez-MateuMTime of progression to osteopenia/osteoporosis in chronically HIV-infected patients: screening DXA scanPLoS One2012710e4603123056229
   PubMed Web of Science ®Google Scholar
• ConstantDRosenbergLZhangYQuantitative ultrasound in relation to risk factors for low bone mineral density in South African pre-menopausal womenArch Osteoporos200941–2556520234859
   PubMedGoogle Scholar
• KriegMABarkmannRGonnelliSQuantitative ultrasound in the management of osteoporosis: the 2007 ISCD Official PositionsJ Clin Densitom200811116318718442758
   PubMed Web of Science ®Google Scholar
• HansDKriegMAQuantitative ultrasound for the detection and management of osteoporosisSalud Publica Mex200951Suppl 1S25S3719287890
   PubMed Web of Science ®Google Scholar
• MoayyeriAAdamsJEAdlerRAQuantitative ultrasound of the heel and fracture risk assessment: an updated meta-analysisOsteoporos Int201223114315322037972
   PubMed Web of Science ®Google Scholar
• CohenMHHottonALHershowRCGender-related risk factors improve mortality predictive ability of VACS Index among HIV-infected womenJ Acquir Immune Defic Syndr201570553854426284531
   PubMed Web of Science ®Google Scholar
• NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis and TherapyOsteoporosis prevention, diagnosis and therapyJAMA2001285678579511176917
   PubMed Web of Science ®Google Scholar
• GrundBPengGGibertCLINSIGHT SMART Body Composition Substudy Group. Continuous antiretroviral therapy decreases bone mineral densityAIDS200923121519152919531929
   PubMed Web of Science ®Google Scholar
• MooreALVashishtASabinCAReduced bone mineral density in HIV-positive individualsAIDS200115131731173311546951
   PubMed Web of Science ®Google Scholar
• DolanSEHuangJSKillileaKMSullivanMPAliabadiNGrinspoonSReduced bone density in HIV-infected womenAIDS200418347548315090800
   PubMed Web of Science ®Google Scholar
• JonesSRestrepoDKasowitzARisk factors for decreased bone density and effects of HIV on bone in the elderlyOsteoporos Int200719791391818071649
   PubMed Web of Science ®Google Scholar
• BorderiMCalzaLColangeliVPrevalence of sub-clinical vertebral fractures in HIV-infected patientsNew Microbiol2014371253224531168
   PubMed Web of Science ®Google Scholar
• StagiSCavalliLBertiniFVitamin D levels in children, adolescents, and young adults with juvenile-onset systemic lupus erythematosus: a cross-sectional studyLupus201423101059106524731961
   PubMed Web of Science ®Google Scholar
• GrantPMKitchDMcComseyGALow baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiationClin Infect Dis201357101483148823943825
   PubMed Web of Science ®Google Scholar
• NegredoEDiez-PérezABonjochASwitching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: changes in bone turnover markers and circulating sclerostin levelsJ Antimicrob Chemother20157072104210725769303
   PubMed Web of Science ®Google Scholar
• OtokunINaLHLandovitzRJComparison of the metabolic effects of ritonavir-boosted darunavir or atazanavir versus raltegravir, and the impact of ritonavir plasma exposure: ACTG 5257Clin Infect Dis201560121842185125767256
   PubMed Web of Science ®Google Scholar